India Exchange Filings

Sai Parenterals to Acquire Majority Stake in Bion Therapeutics’ Prescription Business

Sai Parenterals Ltd subsidiary to acquire majority stake in Bion Therapeutics’ prescription business

  • SP Analytics signed a definitive agreement for an all-cash transaction, expected to close before end-November 2026.
  • Bion brings 16 established brands, about 250 field staff, coverage across 12 states and a network serving around 20,000 doctors.
  • Funding will come from internal accruals, debt and part of IPO proceeds allocated for general corporate purposes; Bion’s management team will continue to lead the business.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.